323 related articles for article (PubMed ID: 32957741)
21. HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case report.
Cabel L; Bidard FC; Servois V; Cacheux W; Mariani P; Romano E; Minsat M; Bieche I; Farkhondeh F; Jeannot E; Buecher B
Int J Cancer; 2017 Oct; 141(8):1667-1670. PubMed ID: 28670746
[TBL] [Abstract][Full Text] [Related]
22. Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatin.
Sebag-Montefiore D; Meadows HM; Cunningham D; Plowman PN; Hurman DC; Davidson N; Grieve R; Levine E; Glynne-Jones R
Radiother Oncol; 2012 Aug; 104(2):155-60. PubMed ID: 22857859
[TBL] [Abstract][Full Text] [Related]
23. The Presence of Serum p53 Antibody Predicts the Pathological Tumor Response to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and Fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma.
Hiyoshi Y; Yoshida N; Watanabe M; Kurashige J; Baba Y; Sakamoto Y; Baba H
World J Surg; 2017 Feb; 41(2):480-486. PubMed ID: 27637603
[TBL] [Abstract][Full Text] [Related]
24. FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer.
Mondaca S; Chatila WK; Bates D; Hechtman JF; Cercek A; Segal NH; Stadler ZK; Varghese AM; Kundra R; Capanu M; Shia J; Schultz N; Saltz L; Yaeger R
Clin Colorectal Cancer; 2019 Mar; 18(1):e39-e52. PubMed ID: 30316684
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of docetaxel, cisplatin, and 5-fluorouracil chemotherapy for superficial esophageal squamous cell carcinoma.
Miyawaki Y; Nakajima Y; Kawada K; Okada T; Tokairin Y; Kawano T
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27001629
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Advantage of Docetaxel/Cisplatin/ 5-Fluorouracil Neoadjuvant Chemotherapy in Clinical Stage II/III Esophageal Squamous Cell Carcinoma due to Excellent Control of Preoperative Disease and Postoperative Lymph Node Recurrence.
Yamashita K; Hosoda K; Moriya H; Katada C; Sugawara M; Mieno H; Komori S; Katada N; Watanabe M
Oncology; 2017; 92(4):221-228. PubMed ID: 28110330
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant chemotherapy of triplet regimens of docetaxel/cisplatin/5-FU (DCF NAC) may improve patient prognosis of cStage II/III esophageal squamous cell carcinoma-propensity score analysis.
Yamashita K; Katada N; Moriya H; Hosoda K; Mieno H; Katada C; Koizumi W; Hoshi K; Watanabe M
Gen Thorac Cardiovasc Surg; 2016 Apr; 64(4):209-15. PubMed ID: 26868531
[TBL] [Abstract][Full Text] [Related]
28. Systemic Therapies for Advanced Squamous Cell Anal Cancer.
Sclafani F; Rao S
Curr Oncol Rep; 2018 May; 20(7):53. PubMed ID: 29728940
[TBL] [Abstract][Full Text] [Related]
29. New approaches in palliative systemic therapy of anal squamous cell carcinoma.
Lohynská R; Pechačová Z
Klin Onkol; 2022; 35(3):190-194. PubMed ID: 35760571
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus infection and tumours of the anal canal: correlation of histology, PCR detection in paraffin sections and serology.
Tachezy R; Jirasek T; Salakova M; Ludvikova V; Kubecova M; Horak L; Mandys V; Hamsikova E
APMIS; 2007 Mar; 115(3):195-203. PubMed ID: 17367464
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal.
Morris V; Rao X; Pickering C; Foo WC; Rashid A; Eterovic K; Kim T; Chen K; Wang J; Shaw K; Eng C
Mol Cancer Res; 2017 Nov; 15(11):1542-1550. PubMed ID: 28784613
[TBL] [Abstract][Full Text] [Related]
32. Docetaxel and Cisplatin Plus Fluorouracil compared with Modified Docetaxel, Cisplatin, and 5-Fluorouracil as first-line therapy for advanced gastric cancer: a retrospective analysis of single institution.
Inal A; Kaplan MA; Kucukoner M; Isikdogan A
Neoplasma; 2012; 59(2):233-6. PubMed ID: 22248282
[TBL] [Abstract][Full Text] [Related]
33. A comparative analysis on clinical efficacy of FOLFOX6 regimen and DCF regimen as neoadjuvant chemotherapy combined with radical gastrectomy in treating advanced gastric cancer.
Tai Q; Shao H; Liu Y; Li E; Zhao R
J BUON; 2019; 24(5):2006-2012. PubMed ID: 31786868
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor receptor inhibition in metastatic anal cancer.
Rogers JE; Ohinata A; Silva NN; Mehdizadeh A; Eng C
Anticancer Drugs; 2016 Sep; 27(8):804-8. PubMed ID: 27272412
[TBL] [Abstract][Full Text] [Related]
35. Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation.
Ajani JA; Wang X; Izzo JG; Crane CH; Eng C; Skibber JM; Das P; Rashid A
Dig Dis Sci; 2010 Apr; 55(4):1098-105. PubMed ID: 19399614
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus vaccines and anal carcinoma.
Franceschi S; De Vuyst H
Curr Opin HIV AIDS; 2009 Jan; 4(1):57-63. PubMed ID: 19339940
[TBL] [Abstract][Full Text] [Related]
37. Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood.
Boustani J; Joseph ELM; Martin E; Benhmida S; Lecoester B; Tochet F; Mirjolet C; Chevalier C; Thibouw D; Vulquin N; Servagi S; Sun X; Adotévi O
BMC Immunol; 2021 Jun; 22(1):38. PubMed ID: 34144673
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
[TBL] [Abstract][Full Text] [Related]
39. A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma.
Katada C; Sugawara M; Hara H; Fujii H; Nakajima TE; Ando T; Kojima T; Watanabe A; Sakamoto Y; Ishikawa H; Hosokawa A; Hamamoto Y; Muto M; Tahara M; Koizumi W
Jpn J Clin Oncol; 2021 Feb; 51(2):199-204. PubMed ID: 33147611
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell Anal Cancer.
Mai S; Welzel G; Ottstadt M; Lohr F; Severa S; Prigge ES; Wentzensen N; Trunk MJ; Wenz F; von Knebel-Doeberitz M; Reuschenbach M
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):819-27. PubMed ID: 26530750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
